Global Health Data Exchange - Discover the World's Health Data

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

Nav

General Info
Geography 
Argentina (ARG)
Austria (AUT)
Canada (CAN)
Chile (CHL)
China (CHN)
Hong Kong
Congo (COG)
Brazzaville
Denmark (DNK)
Germany (DEU)
Honduras (HND)
Francisco Morazán
Hungary (HUN)
Israel (ISR)
Italy (ITA)
Japan (JPN)
Malaysia (MYS)
Mexico (MEX)
Peru (PER)
Portugal (PRT)
Singapore (SGP)
Slovakia (SVK)
Port of Spain
Puerto Rico
Venezuela (VEN)
Time period covered 
01/2001 - 12/2001
Citation
Authors 
Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving HH, Remuzzi G, Snapinn SM, Zhang Z, Shahinfar S, RENAAL Study Investigators
Journal 
N Engl J Med
Volume 
345
Issue 
12
Pages 
861-9
Publication year 
2001
Suggested citation 
Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving HH, Remuzzi G, Snapinn SM, Zhang Z, Shahinfar S, RENAAL Study Investigators. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med. 2001; 345(12): 861-9.